Series A - Indapta Therapeutics
Investment Firm
Overview
Indapta Therapeutics is a privately held biotechnology company.
Announced Date
Feb 10, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Vertex Ventures
Vertex Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.
RA Capital Management
RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Leaps by Bayer
Leaps by Bayer is a early_stage_venture firm.
Participant Investors
5
Round Details and Background
Indapta Therapeutics raised $50000000 on 2022-02-10 in Series A
Indapta Therapeutics is a privately held biotechnology company.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 08, 2021 |  Venture Round - Indapta Therapeutics | 1 | - | undefined |
| May 09, 2019 | Pre Seed Round - Indapta Therapeutics | 1 | - | undefined |
| Jan 15, 2018 | Pre Seed Round - Indapta Therapeutics | 1 | - | undefined |
| May 21, 2024 | Grant - Indapta Therapeutics | 1 | - | 4.5M |